Literature DB >> 10489851

Obstructive sleep apnoea in acromegaly: the role of craniofacial changes.

W Hochban1, K Ehlenz, R Conradt, U Brandenburg.   

Abstract

Obstructive sleep apnoea (OSA) is due to craniofacial changes and acromegaly. The question addressed by this study was whether growth hormone (GH) induced craniofacial changes might explain persisting OSA despite endocrine inactivity in acromegaly. Nineteen patients treated for acromegaly were examined cephalometrically for craniofacial changes and polysomnographically for OSA. Twelve patients proved to have OSA with an apnoea/hypopnoea index >15; seven patients showed no evidence of OSA at all. With respect to the endocrinological parameters, there were no differences between the two groups that would explain the presence or absence of OSA. Neither group differed with respect to sex, age, or body mass index. Craniofacial changes were predominantly found in the mandible. The group with OSA proved to have increased vertical, dolichofacial growth compared to those without OSA. Consecutively, in the OSA group the posterior airway space was narrowed, and the hyoid was displaced more caudally. Thus, it seems that craniofacial structures of patients with acromegaly and persisting obstructive sleep apnoea are different from those without obstructive sleep apnoea. Surgical corrections of pertaining acromegaly-induced craniofacial changes should be performed with an awareness of the individual craniofacial condition so as not to enhance obstructive sleep apnoea.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489851     DOI: 10.1034/j.1399-3003.1999.14a33.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  21 in total

1.  Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters.

Authors:  L Vannucci; P Luciani; E Gagliardi; S Paiano; R Duranti; G Forti; A Peri
Journal:  J Endocrinol Invest       Date:  2012-07-09       Impact factor: 4.256

2.  Peculiarities of clinical profile of snoring and mild to moderate obstructive sleep apnea-hypopnea syndrome patients.

Authors:  Tomas Balsevičius; Virgilijus Uloza; Raimundas Sakalauskas; Skaidrius Miliauskas
Journal:  Sleep Breath       Date:  2011-09-03       Impact factor: 2.816

3.  Screening of acromegaly in adults with obstructive sleep apnea: is it worthwhile?

Authors:  Pierre Attal; Philippe Chanson
Journal:  Endocrine       Date:  2018-05-22       Impact factor: 3.633

4.  Three-dimensional facial analysis in acromegaly: a novel tool to quantify craniofacial characteristics after long-term remission.

Authors:  M A E M Wagenmakers; S H P P Roerink; T J J Maal; R H Pelleboer; J W A Smit; A R M M Hermus; S J Bergé; R T Netea-Maier; T Xi
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

5.  Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesity.

Authors:  Mahssa Karimi; Josef Koranyi; Celina Franco; Yüksel Peker; Derek N Eder; Jan-Erik Angelhed; Lars Lönn; Ludger Grote; Bengt-Ake Bengtsson; Johan Svensson; Jan Hedner; Gudmundur Johannsson
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

6.  Elevated incidence of sleep apnoea in acromegaly-correlation to disease activity.

Authors:  J Roemmler; B Gutt; R Fischer; S Vay; A Wiesmeth; M Bidlingmaier; J Schopohl; M Angstwurm
Journal:  Sleep Breath       Date:  2012-01-13       Impact factor: 2.816

7.  Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients.

Authors:  Cinzia Castellani; Giuseppe Francia; Luca Dalle Carbonare; Marcello Ferrari; Elena Viva; Roberto Cerini; Alessandro Zaccarella; Lorenzo Trevisiol; Maria Vittoria Davi'
Journal:  Endocrine       Date:  2015-06-21       Impact factor: 3.633

8.  Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group.

Authors:  E De Menis; A Giustina; A Colao; E Degli Uberti; E Ghigo; F Minuto; F Bogazzi; R Drigo; A Cattaneo; G Aimaretti
Journal:  J Endocrinol Invest       Date:  2011-01       Impact factor: 4.256

9.  Craniofacial abnormalities, obesity, and hormonal alterations have similar effects in magnitude on the development of nocturnal hypoxemia in patients with acromegaly.

Authors:  M P Rodrigues; L A Naves; L A Casulari; C M Silva; W D Paula; M T Cabral; R R Araujo; C A Viegas
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

10.  The posterior pharyngeal wall thickness is associated with OSAHS in patients with acromegaly and correlates with IGF-1 levels.

Authors:  Xiaopeng Guo; Yumo Zhao; Man Wang; Lu Gao; Zihao Wang; Zhuhua Zhang; Bing Xing
Journal:  Endocrine       Date:  2018-06-21       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.